Pressurised metered dose inhalers containing solutions of beta-2 agonists

Details for Australian Patent Application No. 2003210370 (hide)

Owner Chiesi Farmaceutici S.p.A.

Inventors Lewis, David Andrew; Davies, Rebecca Jaine; Meakin, Brian John; Brambilla, Gaetano; Ganderton, David; Ferraris, Alessandra; Church, Tanya Kathleen

Agent Lord and Company

Pub. Number AU-B-2003210370

PCT Number PCT/EP03/02004

PCT Pub. Number WO2003/074025

Priority 02004786.6 01.03.02 EP; 02023589.1 23.10.02 EP

Filing date 27 February 2003

Wipo publication date 16 September 2003

Acceptance publication date 30 August 2007

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/00 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 11/16 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 02004786.6 01.03.02 EP; 02023589.1 23.10.02 EP

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003210370

30 August 2007 Application Accepted

  Published as AU-B-2003210370

1 November 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Oct 2007. Address for service in Australia - Lord and Company 4 Douro Place West Perth WA 6005

31 January 2008 Standard Patent Sealed

13 March 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Oct 2007 2003244594 GC Corporation The nature of the amendment is as shown in the statement(s) filed 14 Jun 2007

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210371-CONTAINER LASHING DEVICE

2003210369-METHOD AND SYSTEM FOR PROVIDING INFORMATION SERVICES TO A CLIENT USING A USER PROFILE